Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Uzbekistan Short of HIV Drugs

A shortage of retroviral medicines used to treat HIV/AIDS in Uzbekistan is being put down to the government’s policy of understating national infection rates, and hence the amount of drugs it needs to buy.

Published
31 January 2013
From
Institute for War and Peace Reporting
Tenofovir impairs enzyme that stops cells ageing

A team of Australian researchers has found that tenofovir and, to a lesser extent, other drugs from the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) class, impairs an enzyme that

Published
31 January 2013
By
Gus Cairns
Mark S. King: I'm Gonna Wipe That AIDS Right Off My Face

It was all well and good to be front and center as an HIV-positive man during the first years of the AIDS crisis. It's easier being a role model when your face looks good on the poster. But then, slowly but surely, a common side effect of HIV medications, facial wasting, began to appear.

Published
30 January 2013
From
Huffington Post
Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy

HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses than those receiving standard care, according to a new study.

Published
30 January 2013
From
Science Daily
Spanish research shows that liver stiffness can predict outcomes in people co-infected with HIV and hepatitis C

Liver stiffness is a strong predictor of hepatic complications and all-cause mortality in people co-infected with HIV and hepatitis C virus (HCV), Spanish investigators report in the

Published
30 January 2013
By
Michael Carter
Systematic review confirms that efavirenz is a safer option than nevirapine for adults and children starting HIV therapy

Efavirenz is a safer option than nevirapine for adults and children starting antiretroviral therapy, according to the results of a meta-analysis published in the online edition of

Published
29 January 2013
By
Michael Carter
Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV

The Phase 3 studies will examine a once-daily single tablet regimen of TAF 10 mg/elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg compared to Gilead’s Stribild®(elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) among patients new to HIV therapy.

Published
25 January 2013
From
Gilead press release
Gilead petitions FDA over its Stribild AIDS med

In a challenge to FDA decisionmaking that will be closely watched by the pharmaceutical industry, Gilead Sciences has asked the agency to grant five years of exclusivity to its recently approved Stribild AIDS medication.

Published
25 January 2013
From
Pharmalot
Pitt team finds 'Achilles Heel' of key HIV replication protein

Previous research demonstrated that a small HIV protein called Nef interacts with many other proteins in infected cells to help the virus multiply and hide from the immune system. The Pitt group developed a way to track Nef activity in high-throughput drug screening protocols by linking it to an enzyme called Hck, which is activated by Nef in HIV-infected cells.

Published
25 January 2013
From
Eurekalert (press release)
Mortality rates continue to fall in the Swiss HIV cohort

Mortality in people with HIV is continuing to fall, Swiss investigators report in HIV Medicine. The mortality rate in 2010 was a little over 1% and the

Published
25 January 2013
By
Michael Carter

Filter by country